Amedisys Inc Share Price (NASDAQ: AMED)

$100.98

Last updated on August 13, 2025 at 12:00 AM IST

$₹

The stock has been delisted from the stock exchange on 13 Aug 2025

Check the interactive Amedisys Inc Stock chart to analyse performance

Amedisys Inc Key Stats

Check Amedisys Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$100.98
Open	$101.02
Market Capitalization	$3.3B
Today's Volume	$592.7K
Revenue TTM	$2.4B
EBITDA	$253.1M
Earnings Per Share (EPS)	$2.57
PE Ratio	39.28
Profit Margin	3.56%
Quarterly Earnings Growth YOY	-0.14%
Return On Equity TTM	6.67%

Global Institutional Holdings in Amedisys Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
9.93%
Vanguard Group Inc
9.72%
Pentwater Capital Management LP
4.09%
Eckert Corp
3.34%
State Street Corp
3.06%
Fidelity International Ltd
2.67%

Analyst Recommendation on Amedisys Inc Stock

Rating

Trend

Hold

44%Buy

50%Hold

5%Sell

Based on 18 Wall street analysts offering stock ratings for Amedisys Inc(by analysts ranked 0 to 5 stars)

Amedisys Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$2.0B	↑ 17.63%
Net Income	$126.8M	↑ 6.27%
Net Profit Margin	6.49%	↓ 0.69%

	FY20	Y/Y Change
Revenue	$2.1B	↑ 5.93%
Net Income	$183.6M	↑ 44.76%
Net Profit Margin	8.86%	↑ 2.37%

	FY21	Y/Y Change
Revenue	$2.2B	↑ 6.88%
Net Income	$209.1M	↑ 13.87%
Net Profit Margin	9.44%	↑ 0.58%

	FY22	Y/Y Change
Revenue	$2.2B	↑ 0.41%
Net Income	$118.6M	↓ 43.27%
Net Profit Margin	5.34%	↓ 4.1%

	FY23	Y/Y Change
Revenue	$2.2B	↑ 0.59%
Net Income	$-9.7M	↓ 108.22%
Net Profit Margin	-0.44%	↓ 5.78%

	FY24	Y/Y Change
Revenue	$2.3B	↑ 5.01%
Net Income	$43.2M	↓ 543.53%
Net Profit Margin	1.84%	↑ 2.28%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$571.4M	↑ 0.11%
Net Income	$14.4M	↓ 63.43%
Net Profit Margin	2.52%	↓ 4.38%

	Q2 FY24	Q/Q Change
Revenue	$591.2M	↑ 3.46%
Net Income	$32.3M	↑ 124.31%
Net Profit Margin	5.46%	↑ 2.94%

	Q3 FY24	Q/Q Change
Revenue	$587.7M	↓ 0.59%
Net Income	$41.5M	↑ 28.36%
Net Profit Margin	7.05%	↑ 1.59%

	Q4 FY24	Q/Q Change
Revenue	$598.1M	↑ 1.77%
Net Income	$-20.4M	↓ 149.16%
Net Profit Margin	-3.41%	↓ 10.46%

	Q1 FY25	Q/Q Change
Revenue	$594.8M	↓ 0.55%
Net Income	$61.0M	↓ 399.36%
Net Profit Margin	10.26%	↑ 13.67%

	Q2 FY25	Q/Q Change
Revenue	$621.9M	↑ 4.55%
Net Income	$67.6M	↑ 10.8%
Net Profit Margin	10.87%	↑ 0.61%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$805.3M	↑ 20.24%

	FY20	Y/Y Change
Profit	$886.2M	↑ 10.04%

	FY21	Y/Y Change
Profit	$980.8M	↑ 10.68%

	FY22	Y/Y Change
Profit	$962.8M	↓ 1.83%

	FY23	Y/Y Change
Profit	$990.9M	↑ 2.92%

	FY24	Y/Y Change
Profit	$1.0B	↑ 2.71%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$117.7M	↓ 72.65%

	Q2 FY24	Q/Q Change
Profit	$130.5M	↑ 10.95%

	Q3 FY24	Q/Q Change
Profit	$250.1M	↑ 91.59%

	Q4 FY24	Q/Q Change
Profit	$253.4M	↑ 1.33%

	Q1 FY25	Q/Q Change
Profit	$260.7M	↑ 2.88%

	Q2 FY25	Q/Q Change
Profit	$491.5M	↑ 88.52%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$202.0M	↓ 9.61%
Investing Cash Flow	$-352.9M	↑ 1490.36%
Financing Cash Flow	$227.2M	↓ 184.96%

	FY20	Y/Y Change
Operating Cash Flow	$289.0M	↑ 43.05%
Investing Cash Flow	$-287.1M	↓ 18.65%
Financing Cash Flow	$-15.0M	↓ 106.59%

	FY21	Y/Y Change
Operating Cash Flow	$188.9M	↓ 34.63%
Investing Cash Flow	$-281.6M	↓ 1.92%
Financing Cash Flow	$55.1M	↓ 468.07%

	FY22	Y/Y Change
Operating Cash Flow	$133.3M	↓ 29.44%
Investing Cash Flow	$-94.5M	↓ 66.45%
Financing Cash Flow	$-30.4M	↓ 155.21%

	FY23	Y/Y Change
Operating Cash Flow	$137.2M	↑ 2.93%
Investing Cash Flow	$35.1M	↓ 137.11%
Financing Cash Flow	$-87.5M	↑ 187.59%

	FY24	Y/Y Change
Operating Cash Flow	$221.7M	↑ 61.58%
Investing Cash Flow	$-8.4M	↓ 123.85%
Financing Cash Flow	$-48.9M	↓ 44.1%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-6.5M	↓ 110.85%
Investing Cash Flow	$-1.3M	-
Financing Cash Flow	$-10.3M	↓ 24.41%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$52.3M	↓ 899.65%
Investing Cash Flow	$-1.4M	↑ 9.2%
Financing Cash Flow	$-14.2M	↑ 37.94%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$105.6M	↑ 101.94%
Investing Cash Flow	$-2.4M	↑ 71.7%
Financing Cash Flow	$-15.1M	↑ 6.04%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$70.3M	↓ 33.46%
Investing Cash Flow	$-1.3M	↓ 47.65%
Financing Cash Flow	$-11.2M	↓ 25.73%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-3.7M	↓ 105.25%
Investing Cash Flow	$-1.4M	↑ 7.34%
Financing Cash Flow	$-13.3M	↑ 18.7%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$67.2M	↓ 1922.92%
Investing Cash Flow	$-921.0K	↓ 32.97%
Financing Cash Flow	$-13.9M	↑ 4.26%

About Amedisys Inc

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Organization	Amedisys Inc
Employees	19000
CEO	Mr. Richard M. Ashworth
Industry	Health Services

Key Management of Amedisys Inc

Name	Title
Mr. Richard M. Ashworth	President, CEO & Director
Mr. Scott G. Ginn CPA	Executive VP, COO & CFO
Ms. Jennifer Guckert Griffin	Chief Legal Officer & Corporate Secretary
Ms. Denise Bohnert	Chief Compliance Officer
Mr. Nick Muscato	Chief Strategy Officer
Ms. Allyson Guidroz	Chief Accounting Officer & Principal Accounting Officer
Mr. Pete Hartley	CTO & Senior VP of Business Operations Systems
Mr. Keith Blanchard	Acting Chief Information Officer
Kendra Kimmons	VP of Marketing & Communications & Media Relations
Ms. Caitlin Franklin	Acting Chief People Officer

Important FAQs about investing in AMED Stock from India :

What is Amedisys Inc share price today?

Amedisys Inc share price today is $100.98 as on August 13, 2025 at 12:00 AM IST at the close of the market. Amedisys Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Amedisys Inc share?

Amedisys Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Amedisys Inc stock price today i.e. August 13, 2025 at 12:00 AM IST is closed at $100.98, lower by 0.03% versus the 52 week high.

How to invest in Amedisys Inc Stock (AMED) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Amedisys Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amedisys Inc Shares that will get you 0.0149 shares as per Amedisys Inc share price of $100.98 per share as on August 13, 2025 at 12:00 AM IST.

What is the minimum amount required to buy Amedisys Inc Stock (AMED) from India?

Indian investors can start investing in Amedisys Inc (AMED) shares with as little as ₹87.554 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.54 in Amedisys Inc stock (as per the Rupee-Dollar exchange rate as on August 26, 2025). Based on Amedisys Inc share’s latest price of $100.98 as on August 13, 2025 at 12:00 AM IST, you will get 0.0990 shares of Amedisys Inc. Learn more about fractional shares .

What are the returns that Amedisys Inc has given to Indian investors in the last 5 years?

Amedisys Inc stock has given 0.0% share price returns and 18.05% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?

Discover More

Direxion Dy Csco Bear 1x Etf
$24.50
+1.58%
Bny Mellon Concentrated Intl
$50.65
-0.63%
Orion Energy Systems Inc
$7.35
+18.36%
Tradr 1.5x Short Nvda Daily Etf
$11.83
-1.42%
Venus Concept Inc
$2.56
+4.49%
Virtus Real Asset Income Etf
$23.87
+0.04%
Landmark Bancorp Inc
$26.19
-2.39%
Central Puerto Sa
$10.30
-6.53%
First Trust Flexible Municipal High Income Etf
$16.43
-0.06%

Explore all